Mirum Pharmaceuticals Inc (MIRM)
42.80
+0.76
(+1.81%)
USD |
NASDAQ |
Jan 03, 16:00
42.03
-0.77
(-1.80%)
After-Hours: 05:41
Mirum Pharmaceuticals Research and Development Expense (Annual): 102.61M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Cytokinetics Inc | -- |
| Amicus Therapeutics Inc | 152.38M |
| Ocugen Inc | 39.57M |
| Scholar Rock Holding Corp | 121.90M |
| Arcutis Biotherapeutics Inc | 110.58M |